Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023222
Filing Date
2017-11-09
Accepted
2017-11-09 16:01:39
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vsar-10q_20170930.htm 10-Q 1366813
2 EX-31.1 vsar-ex311_6.htm EX-31.1 16725
3 EX-31.2 vsar-ex312_9.htm EX-31.2 16479
4 EX-32.1 vsar-ex321_10.htm EX-32.1 5189
  Complete submission text file 0001564590-17-023222.txt   3907988

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsar-20170930.xml EX-101.INS 647645
6 XBRL TAXONOMY EXTENSION SCHEMA vsar-20170930.xsd EX-101.SCH 34403
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20170930_cal.xml EX-101.CAL 33346
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20170930_def.xml EX-101.DEF 77169
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20170930_lab.xml EX-101.LAB 241304
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20170930_pre.xml EX-101.PRE 168869
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 171190657
SIC: 2834 Pharmaceutical Preparations